Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
BTM-3566
i
Other names:
BTM-3566
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
Bantam Pharma
Drug class:
EIF-2 kinase modulator
‹
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
MYD88 mutation
Diffuse Large B Cell Lymphoma
MYD88 mutation
Diffuse Large B Cell Lymphoma
BTM-3566
Sensitive: D – Preclinical
BTM-3566
Sensitive
:
D
BTM-3566
Sensitive: D – Preclinical
BTM-3566
Sensitive
:
D
MYC rearrangement + BCL2 rearrangement
Diffuse Large B Cell Lymphoma
MYC rearrangement + BCL2 rearrangement
Diffuse Large B Cell Lymphoma
BTM-3566
Sensitive: D – Preclinical
BTM-3566
Sensitive
:
D
BTM-3566
Sensitive: D – Preclinical
BTM-3566
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login